Korro Bio, Inc.
KRRO
$13.28
-$0.01-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.92M | -19.63M | -50.04M | -18.06M | -25.77M |
| Total Depreciation and Amortization | 365.00K | 380.00K | 649.00K | 1.18M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.95M | 2.98M | 33.14M | 1.96M | 2.17M |
| Change in Net Operating Assets | -1.39M | 196.00K | -1.45M | -2.25M | 3.15M |
| Cash from Operations | -16.99M | -16.07M | -17.70M | -17.18M | -19.23M |
| Capital Expenditure | -37.00K | -21.00K | -84.00K | -175.00K | -140.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.86M | -32.22M | 15.00M | 7.77M | -11.16M |
| Cash from Investing | -17.90M | -32.24M | 14.92M | 7.60M | -11.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 88.21M | 380.00K | 128.00K | 5.00K |
| Repurchase of Common Stock | -2.92M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.92M | 88.21M | 380.00K | 128.00K | 5.00K |
| Foreign Exchange rate Adjustments | 22.00K | -25.00K | 75.00K | -2.00K | -9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.79M | 39.87M | -2.33M | -9.46M | -30.53M |